Literature DB >> 31721409

IL-22 is required for the induction of bronchus-associated lymphoid tissue in tolerant lung allografts.

Satona Tanaka1, Jason M Gauthier1, Anja Fuchs2, Wenjun Li1, Alice Y Tong1, Margaret S Harrison1, Ryuji Higashikubo1, Yuriko Terada1, Ramsey R Hachem3, Daniel Ruiz-Perez4, Jon H Ritter5, Marina Cella5, Marco Colonna5, Isaiah R Turnbull2, Alexander S Krupnick6,7, Andrew E Gelman1,5, Daniel Kreisel1,5.   

Abstract

Long-term survival after lung transplantation remains profoundly limited by graft rejection. Recent work has shown that bronchus-associated lymphoid tissue (BALT), characterized by the development of peripheral nodal addressin (PNAd)-expressing high endothelial venules and enriched in B and Foxp3+ T cells, is important for the maintenance of allograft tolerance. Mechanisms underlying BALT induction in tolerant pulmonary allografts, however, remain poorly understood. Here, we show that the development of PNAd-expressing high endothelial venules within intragraft lymphoid follicles and the recruitment of B cells, but not Foxp3+ cells depends on IL-22. We identify graft-infiltrating gamma-delta (γδ) T cells and Type 3 innate lymphoid cells (ILC3s) as important producers of IL-22. Reconstitution of IL-22 at late time points through retransplantation into wildtype hosts mediates B cell recruitment into lymphoid follicles within the allograft, resulting in a significant increase in their size, but does not induce PNAd expression. Our work has identified cellular and molecular requirements for the induction of BALT in pulmonary allografts during tolerance induction and may provide a platform for the development of new therapies for lung transplant patients.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  animal models: murine; basic (laboratory) research/science; immunobiology; lung transplantation/pulmonology; lymph node; lymphocyte biology; tolerance: experimental

Mesh:

Substances:

Year:  2019        PMID: 31721409      PMCID: PMC7183893          DOI: 10.1111/ajt.15701

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  54 in total

1.  Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection.

Authors:  Fady K Baddoura; Isam W Nasr; Barbara Wrobel; Qi Li; Nancy H Ruddle; Fadi G Lakkis
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

2.  Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response.

Authors:  Olivier Thaunat; Anne-Christine Field; Jianping Dai; Liliane Louedec; Natacha Patey; Marie-Françoise Bloch; Chantal Mandet; Marie-France Belair; Patrick Bruneval; Olivier Meilhac; Blanche Bellon; Etienne Joly; Jean-Baptiste Michel; Antonino Nicoletti
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

Review 3.  Innate Lymphoid Cells: 10 Years On.

Authors:  Eric Vivier; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gérard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Hergen Spits
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

4.  Increase of gammadelta T lymphocytes in murine lungs occurs during recovery from pulmonary infection by Nocardia asteroides.

Authors:  S Tam; D P King; B L Beaman
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium.

Authors:  Naruhisa Ota; Kit Wong; Patricia A Valdez; Yan Zheng; Natasha K Crellin; Lauri Diehl; Wenjun Ouyang
Journal:  Nat Immunol       Date:  2011-08-28       Impact factor: 25.606

6.  Lung transplant acceptance is facilitated by early events in the graft and is associated with lymphoid neogenesis.

Authors:  W Li; A C Bribriesco; R G Nava; A A Brescia; A Ibricevic; J H Spahn; S L Brody; J H Ritter; A E Gelman; A S Krupnick; M J Miller; D Kreisel
Journal:  Mucosal Immunol       Date:  2012-05-02       Impact factor: 7.313

7.  Air pollution and the development of posttransplant chronic lung allograft dysfunction.

Authors:  S Bhinder; H Chen; M Sato; R Copes; G J Evans; C-W Chow; L G Singer
Journal:  Am J Transplant       Date:  2014-10-30       Impact factor: 8.086

8.  Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs.

Authors:  Andrew E Gelman; Wenjun Li; Steven B Richardson; Bernd H Zinselmeyer; Jiaming Lai; Mikio Okazaki; Christopher G Kornfeld; Friederike H Kreisel; Seiichiro Sugimoto; Jeremy R Tietjens; John Dempster; G Alexander Patterson; Alexander S Krupnick; Mark J Miller; Daniel Kreisel
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Type I interferon induces CXCL13 to support ectopic germinal center formation.

Authors:  Alice E Denton; Silvia Innocentin; Edward J Carr; Barry M Bradford; Fanny Lafouresse; Neil A Mabbott; Urs Mörbe; Burkhard Ludewig; Joanna R Groom; Kim L Good-Jacobson; Michelle A Linterman
Journal:  J Exp Med       Date:  2019-02-05       Impact factor: 14.307

10.  Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.

Authors:  Nikhil S Joshi; Elliot H Akama-Garren; Yisi Lu; Da-Yae Lee; Gregory P Chang; Amy Li; Michel DuPage; Tuomas Tammela; Natanya R Kerper; Anna F Farago; Rebecca Robbins; Denise M Crowley; Roderick T Bronson; Tyler Jacks
Journal:  Immunity       Date:  2015-09-01       Impact factor: 31.745

View more
  9 in total

1.  Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance.

Authors:  Wenjun Li; Jason M Gauthier; Alice Y Tong; Yuriko Terada; Ryuji Higashikubo; Christian C Frye; Margaret S Harrison; Kohei Hashimoto; Amit I Bery; Jon H Ritter; Ruben G Nava; Varun Puri; Brian W Wong; Kory J Lavine; Ankit Bharat; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

2.  Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.

Authors:  Yizhan Guo; Zhongcheng Mei; Dongge Li; Anirban Banerjee; May A Khalil; Allen Burke; Jon Ritter; Christine Lau; Daniel Kreisel; Andrew E Gelman; Elizabeth Jacobsen; Irina G Luzina; Sergei P Atamas; Alexander Sasha Krupnick
Journal:  Am J Transplant       Date:  2022-05-17       Impact factor: 9.369

3.  Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases.

Authors:  Melanie Albrecht; Olga Halle; Svenja Gaedcke; Sophia T Pallenberg; Julia Camargo Neumann; Marius Witt; Johanna Roediger; Marina Schumacher; Adan Chari Jirmo; Gregor Warnecke; Danny Jonigk; Peter Braubach; David DeLuca; Gesine Hansen; Anna-Maria Dittrich
Journal:  Clin Transl Immunology       Date:  2022-06-16

4.  Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.

Authors:  Thomas J Lynch; Bethany A Ahlers; Anthony M Swatek; Vitaly Ievlev; Albert C Pai; Leonard Brooks; Yinghua Tang; Idil A Evans; David K Meyerholz; John F Engelhardt; Kalpaj R Parekh
Journal:  Transplantation       Date:  2022-04-15       Impact factor: 5.385

Review 5.  Role of tertiary lymphoid organs in the regulation of immune responses in the periphery.

Authors:  Amit I Bery; Hailey M Shepherd; Wenjun Li; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  Cell Mol Life Sci       Date:  2022-06-11       Impact factor: 9.207

Review 6.  Tolerance, immunosuppression, and immune modulation: impacts on lung allograft survival.

Authors:  Hailey M Shepherd; Jason M Gauthier; Daniel Kreisel
Journal:  Curr Opin Organ Transplant       Date:  2021-06-01       Impact factor: 2.269

Review 7.  Recent advances in our understanding of the allograft response.

Authors:  Conor Hennessy; Guido Lewik; Amy Cross; Joanna Hester; Fadi Issa
Journal:  Fac Rev       Date:  2021-02-25

Review 8.  Therapeutic manipulation of innate lymphoid cells.

Authors:  Laura M Cobb; Michael R Verneris
Journal:  JCI Insight       Date:  2021-03-22

9.  Efficient In Vitro Generation of IL-22-Secreting ILC3 From CD34+ Hematopoietic Progenitors in a Human Mesenchymal Stem Cell Niche.

Authors:  Sabrina B Bennstein; Sandra Weinhold; Özer Degistirici; Robert A J Oostendorp; Katharina Raba; Gesine Kögler; Roland Meisel; Lutz Walter; Markus Uhrberg
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.